Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
LINZESS
Generic name / active ingredient
linaclotide
Dosage-form class
United States: linaclotide 72, 145 and 290 mcg oral capsules. Japan: linaclotide 0.25 mg film-coated oral tablet. The U.S. label permits opening a capsule through specified swallowing-difficulty routes and using the complete contents of one capsule, but not chewing, crushing, visual halving or storing a mixture.
Route
Oral (cross-market exact-product identity field)
Record reviewed
2026-08-29

Copy from the pack in hand

Source-linked reading points

  • 72, 145 and 290 mcg are labelled amounts per capsule, while 30 is the bottle count. A microgram (mcg) is not a milligram (mg): 1 mg equals 1,000 mcg. Unit conversion cannot decide an individual's capsule count, strength change or make-up use.
  • The label does not permit ‘pouring out half’. If the capsule is opened through the swallowing-difficulty route, the complete contents of one capsule are used and administered immediately as specified. Do not chew or crush the beads or split them visually into portions.
  • Severe diarrhoea can cause dehydration. Marked thirst, reduced urination, dizziness, weakness, fainting or mental-status change needs prompt professional help, particularly in an older person, child or someone also using a diuretic; use local emergency services when severe.
  • Known or suspected mechanical gastrointestinal obstruction is a U.S. label contraindication. Persistent severe pain, marked distension, repeated vomiting or inability to pass gas or stool must not be treated as ordinary constipation by simply adding more medicine.

Reviewed presentation examples — compare every field

  • Linaclotide 72 mcg per capsule; 30-capsule bottleNDC 0456-1203-30
  • Linaclotide 145 mcg per capsule; 30-capsule bottleNDC 0456-1201-30
  • Linaclotide 290 mcg per capsule; 30-capsule bottleNDC 0456-1202-30
  • Linaclotide 0.25 mg per tablet; Japanese film-coated tabletPMDA 2399017F1020

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-29
Source record
5 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image